Tumour microenvironment (TME) characterization identified prognosis and immunotherapy response in muscle-invasive bladder cancer (MIBC) Rui CaoLushun YuanYe Tian Original Article 02 July 2020 Pages: 1 - 18
Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC) Gigja GudbrandsdottirHelene H. AarstadChristian Beisland Original Article Open access 03 July 2020 Pages: 19 - 30
Potent anti-myeloma efficacy of dendritic cell therapy in combination with pomalidomide and programmed death-ligand 1 blockade in a preclinical model of multiple myeloma Tan-Huy ChuManh-Cuong VoJe-Jung Lee Original Article 04 July 2020 Pages: 31 - 45
Differential immune microenvironmental features of microsatellite-unstable colorectal cancers according to Fusobacterium nucleatum status Ji Ae LeeSeung-Yeon YooJung Ho Kim Original Article 04 July 2020 Pages: 47 - 59
Romidepsin (FK228) regulates the expression of the immune checkpoint ligand PD-L1 and suppresses cellular immune functions in colon cancer Yehui ShiYing FuHui Li Original Article Open access 06 July 2020 Pages: 61 - 73
CD66b+ monocytes represent a proinflammatory myeloid subpopulation in cancer Utku HorzumDigdem Yoyen-ErmisGunes Esendagli Original Article 06 July 2020 Pages: 75 - 87
Body mass index and immune-related adverse events in patients on immune checkpoint inhibitor therapies: a systematic review and meta-analysis Yuli Guzman-PradoJennifer Ben ShimolOndrej Samson Original Article 09 July 2020 Pages: 89 - 100
Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors Eiki IchiharaDaijiro HaradaKatsuyuki Kiura Original Article 10 July 2020 Pages: 101 - 106
Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses Niklas RemkeSavita BishtPeter Brossart Original Article 10 July 2020 Pages: 107 - 121
Interleukin-38 promotes tumor growth through regulation of CD8+ tumor-infiltrating lymphocytes in lung cancer tumor microenvironment Fumihiko KinoshitaTetsuzo TagawaMasaki Mori Original Article 11 July 2020 Pages: 123 - 135
ZFHX3 mutation as a protective biomarker for immune checkpoint blockade in non-small cell lung cancer Jiexia ZhangNingning ZhouJian Zhang Original Article 11 July 2020 Pages: 137 - 151
TGF-βR inhibitor SB431542 restores immune suppression induced by regulatory B–T cell axis and decreases tumour burden in murine fibrosarcoma Kavitha PremkumarBhavani S. Shankar Original Article 13 July 2020 Pages: 153 - 168
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomas John W. RutlandCorey M. GillMary Fowkes Original Article 13 July 2020 Pages: 169 - 176
Mechanism of action of a T cell-dependent bispecific antibody as a breakthrough immunotherapy against refractory colorectal cancer with an oncogenic mutation Daisuke KamakuraRyutaro AsanoMasahiro Yasunaga Original Article Open access 14 July 2020 Pages: 177 - 188
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC Xuanwen BaoRun ShiWeijia Fang Original Article 17 July 2020 Pages: 189 - 202
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding Jun AraiKaku GotoHitoshi Yoshida Original Article Open access 18 July 2020 Pages: 203 - 213
Human leukocyte antigen expression in paired primary lung tumors and brain metastases in non-small cell lung cancer Jarrett J. FailingMarie Christine AubryAaron S. Mansfield Original Article 21 July 2020 Pages: 215 - 219
Patterns of progression in patients treated for immuno-oncology antibodies combination Alice Bernard-TessierCapucine BaldiniSamy Ammari Original Article 22 July 2020 Pages: 221 - 232
Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model Melisa B. NicoudMónica A. Táquez DelgadoVanina A. Medina Original Article 22 July 2020 Pages: 233 - 244
Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report Mustafa Zafer TemizAykut ColakerolAhmet Yaser Muslumanoglu Original Article 22 July 2020 Pages: 245 - 252
Identification of two distinct populations of WT1-specific cytotoxic T lymphocytes in co-vaccination of WT1 killer and helper peptides Fumihiro FujikiAkihiro TsuboiHaruo Sugiyama Original Article 22 July 2020 Pages: 253 - 263